Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 55 entries
Sorted by: Best Match Show Resources per page
[THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER].

Harefuah

Belilovski Rozenblum A, Ilouze M, Dudnik E, Soussan-Gutman L, Dvir A, Peled N.
PMID: 29198084
Harefuah. 2017 Nov;156(11):686-691.

BACKGROUND: In the last decade, important advances in understanding the lung cancer cellular signal pathways have led to the designing of targeted drugs that significantly prolong survival. Recent data shows that 64% of lung adenocarcinomas harbor at least one...

Cite
Belilovski Rozenblum A, Ilouze M, Dudnik E, et al. [THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER]. Harefuah. 2017;156(11):686-691
Belilovski Rozenblum, A., Ilouze, M., Dudnik, E., Soussan-Gutman, L., Dvir, A., & Peled, N. (2017). [THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER]. Harefuah, 156(11), 686-691.
Belilovski Rozenblum, Anna, et al. "[THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER]." Harefuah vol. 156,11 (2017): 686-691.
Belilovski Rozenblum A, Ilouze M, Dudnik E, Soussan-Gutman L, Dvir A, Peled N. [THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER]. Harefuah. 2017 Nov;156(11):686-691. Hebrew. PMID: 29198084.
Copy Download .nbib Format: NLM
Clinical and functional significance of a novel ferroptosis-related prognosis signature in lung adenocarcinoma.

Clinical and translational medicine

Wang Z, Diao J, Zhao X, Xu Z, Zhang X.
PMID: 33784012
Clin Transl Med. 2021 Mar;11(3):e364. doi: 10.1002/ctm2.364.

No abstract available.

Cite
Wang Z, Diao J, Zhao X, et al. Clinical and functional significance of a novel ferroptosis-related prognosis signature in lung adenocarcinoma. Clin Transl Med. 2021;11(3):e364doi: 10.1002/ctm2.364.
Wang, Z., Diao, J., Zhao, X., Xu, Z., & Zhang, X. (2021). Clinical and functional significance of a novel ferroptosis-related prognosis signature in lung adenocarcinoma. Clinical and translational medicine, 11(3), e364. https://doi.org/10.1002/ctm2.364
Wang, Ziqi, et al. "Clinical and functional significance of a novel ferroptosis-related prognosis signature in lung adenocarcinoma." Clinical and translational medicine vol. 11,3 (2021): e364. doi: https://doi.org/10.1002/ctm2.364
Wang Z, Diao J, Zhao X, Xu Z, Zhang X. Clinical and functional significance of a novel ferroptosis-related prognosis signature in lung adenocarcinoma. Clin Transl Med. 2021 Mar;11(3):e364. doi: 10.1002/ctm2.364. PMID: 33784012; PMCID: PMC7968124.
Copy Download .nbib Format: NLM
Single Living Cell Analysis Nanoplatform for High-Throughput Interrogation of Gene Mutation and Cellular Behavior.

Nano letters

Dong Z, Yan S, Liu B, Hao Y, Lin L, Chang T, Sun H, Wang Y, Li H, Wu H, Hang X, He S, Hu J, Xue X, Wu N, Chang L.
PMID: 33830766
Nano Lett. 2021 Jun 09;21(11):4878-4886. doi: 10.1021/acs.nanolett.1c00199. Epub 2021 Apr 08.

The genetic heterogeneities in cancer cells pose challenges to achieving precise drug treatment in a widely applicable manner. Most single-cell gene analysis methods rely on cell lysis for gene extraction and identification, showing limited capacity to provide the correlation...

Cite
Dong Z, Yan S, Liu B, et al. Single Living Cell Analysis Nanoplatform for High-Throughput Interrogation of Gene Mutation and Cellular Behavior. Nano Lett. 2021;21(11):4878-4886doi: 10.1021/acs.nanolett.1c00199.
Dong, Z., Yan, S., Liu, B., Hao, Y., Lin, L., Chang, T., Sun, H., Wang, Y., Li, H., Wu, H., Hang, X., He, S., Hu, J., Xue, X., Wu, N., & Chang, L. (2021). Single Living Cell Analysis Nanoplatform for High-Throughput Interrogation of Gene Mutation and Cellular Behavior. Nano letters, 21(11), 4878-4886. https://doi.org/10.1021/acs.nanolett.1c00199
Dong, Zaizai, et al. "Single Living Cell Analysis Nanoplatform for High-Throughput Interrogation of Gene Mutation and Cellular Behavior." Nano letters vol. 21,11 (2021): 4878-4886. doi: https://doi.org/10.1021/acs.nanolett.1c00199
Dong Z, Yan S, Liu B, Hao Y, Lin L, Chang T, Sun H, Wang Y, Li H, Wu H, Hang X, He S, Hu J, Xue X, Wu N, Chang L. Single Living Cell Analysis Nanoplatform for High-Throughput Interrogation of Gene Mutation and Cellular Behavior. Nano Lett. 2021 Jun 09;21(11):4878-4886. doi: 10.1021/acs.nanolett.1c00199. Epub 2021 Apr 08. PMID: 33830766.
Copy Download .nbib Format: NLM
Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer.

Cancer biomarkers : section A of Disease markers

Meng F, Zhang L, Ren Y, Ma Q.
PMID: 32831194
Cancer Biomark. 2020;29(4):475-482. doi: 10.3233/CBM-200110.

Previous studies have suggested potential signature genes for lung cancer, however, due to factors such as sequencing platform, control, data selection and filtration conditions, the results of lung cancer-related gene expression analysis are quite different. Here, we performed a...

Cite
Meng F, Zhang L, Ren Y, et al. Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer. Cancer Biomark. 2020;29(4):475-482doi: 10.3233/CBM-200110.
Meng, F., Zhang, L., Ren, Y., & Ma, Q. (2020). Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer. Cancer biomarkers : section A of Disease markers, 29(4), 475-482. https://doi.org/10.3233/CBM-200110
Meng, Fanlu, et al. "Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer." Cancer biomarkers : section A of Disease markers vol. 29,4 (2020): 475-482. doi: https://doi.org/10.3233/CBM-200110
Meng F, Zhang L, Ren Y, Ma Q. Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer. Cancer Biomark. 2020;29(4):475-482. doi: 10.3233/CBM-200110. PMID: 32831194.
Copy Download .nbib Format: NLM
[Lung Adenocarcinomas with Pulmonary Miliary Metastases: A Case Report and Literature Review].

Zhongguo fei ai za zhi = Chinese journal of lung cancer

Li L, Zhou L, Zhang J.
PMID: 31874677
Zhongguo Fei Ai Za Zhi. 2019 Dec 20;22(12):798-804. doi: 10.3779/j.issn.1009-3419.2019.12.11.

BACKGROUND: Lung adenocarcinoma with miliary metastasis in both lungs is easily misdiagnosed. The aim of this study is to investigate the clinical features of lung adenocarcinoma with miliary metastases in both lungs and to improve the clinician's understanding of...

Cite
Li L, Zhou L, Zhang J. [Lung Adenocarcinomas with Pulmonary Miliary Metastases: A Case Report and Literature Review]. Zhongguo Fei Ai Za Zhi. 2019;22(12):798-804doi: 10.3779/j.issn.1009-3419.2019.12.11.
Li, L., Zhou, L., & Zhang, J. (2019). [Lung Adenocarcinomas with Pulmonary Miliary Metastases: A Case Report and Literature Review]. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 22(12), 798-804. https://doi.org/10.3779/j.issn.1009-3419.2019.12.11
Li, Linxue, et al. "[Lung Adenocarcinomas with Pulmonary Miliary Metastases: A Case Report and Literature Review]." Zhongguo fei ai za zhi = Chinese journal of lung cancer vol. 22,12 (2019): 798-804. doi: https://doi.org/10.3779/j.issn.1009-3419.2019.12.11
Li L, Zhou L, Zhang J. [Lung Adenocarcinomas with Pulmonary Miliary Metastases: A Case Report and Literature Review]. Zhongguo Fei Ai Za Zhi. 2019 Dec 20;22(12):798-804. doi: 10.3779/j.issn.1009-3419.2019.12.11. Chinese. PMID: 31874677; PMCID: PMC6935038.
Copy Download .nbib Format: NLM
Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma.

Lung cancer (Amsterdam, Netherlands)

Tamura N, Fujiwara Y, Hashimoto T, Shiraishi H, Kitano S, Shimizu T, Kuwano K, Yamamoto N, Motoi N.
PMID: 32450493
Lung Cancer. 2020 Jul;145:152-157. doi: 10.1016/j.lungcan.2020.05.002. Epub 2020 May 11.

OBJECTIVES: Folate receptor alpha (FRα) is expressed on the cell surface, mediates its intracellular transport via receptor-mediated endocytosis, and is involved in cell division. Whether FRα could be a potential therapeutic target in FRα-expressing cancers remains unknown. Here, we...

Cite
Tamura N, Fujiwara Y, Hashimoto T, et al. Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma. Lung Cancer. 2020;145:152-157doi: 10.1016/j.lungcan.2020.05.002.
Tamura, N., Fujiwara, Y., Hashimoto, T., Shiraishi, H., Kitano, S., Shimizu, T., Kuwano, K., Yamamoto, N., & Motoi, N. (2020). Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands), 145152-157. https://doi.org/10.1016/j.lungcan.2020.05.002
Tamura, Nobumasa, et al. "Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma." Lung cancer (Amsterdam, Netherlands) vol. 145 (2020): 152-157. doi: https://doi.org/10.1016/j.lungcan.2020.05.002
Tamura N, Fujiwara Y, Hashimoto T, Shiraishi H, Kitano S, Shimizu T, Kuwano K, Yamamoto N, Motoi N. Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma. Lung Cancer. 2020 Jul;145:152-157. doi: 10.1016/j.lungcan.2020.05.002. Epub 2020 May 11. PMID: 32450493.
Copy Download .nbib Format: NLM
Targeting Epigenetics in Lung Cancer.

Cold Spring Harbor perspectives in medicine

Chao YL, Pecot CV.
PMID: 32900703
Cold Spring Harb Perspect Med. 2021 Jun 01;11(6). doi: 10.1101/cshperspect.a038000.

The epigenetic landscape, which in part includes DNA methylation, chromatin organization, histone modifications, and noncoding RNA regulation, greatly contributes to the heterogeneity that makes developing effective therapies for lung cancer challenging. This review will provide an overview of the...

Cite
Chao YL, Pecot CV. Targeting Epigenetics in Lung Cancer. Cold Spring Harb Perspect Med. 2021;11(6)doi: 10.1101/cshperspect.a038000.
Chao, Y. L., & Pecot, C. V. (2021). Targeting Epigenetics in Lung Cancer. Cold Spring Harbor perspectives in medicine, 11(6), . https://doi.org/10.1101/cshperspect.a038000
Chao, Yvonne L, and Pecot, Chad V. "Targeting Epigenetics in Lung Cancer." Cold Spring Harbor perspectives in medicine vol. 11,6 (2021). doi: https://doi.org/10.1101/cshperspect.a038000
Chao YL, Pecot CV. Targeting Epigenetics in Lung Cancer. Cold Spring Harb Perspect Med. 2021 Jun 01;11(6). doi: 10.1101/cshperspect.a038000. PMID: 32900703; PMCID: PMC8168531.
Copy Download .nbib Format: NLM
[Polygenic risk score in personalized screening of lung cancer: a prospective cohort study in Chinese].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Zhu M, Lyu J, Yu CQ, Huang YQ, Ma HX, Jin GF, Guo Y, Pei P, Chen ZM, Shen HB, Hu ZB, Li LM.
PMID: 34814406
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Mar 10;42(3):376-381. doi: 10.3760/cma.j.cn112338-20210107-00013.

No abstract available.

Cite
Zhu M, Lyu J, Yu CQ, et al. [Polygenic risk score in personalized screening of lung cancer: a prospective cohort study in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42(3):376-381doi: 10.3760/cma.j.cn112338-20210107-00013.
Zhu, M., Lyu, J., Yu, C. Q., Huang, Y. Q., Ma, H. X., Jin, G. F., Guo, Y., Pei, P., Chen, Z. M., Shen, H. B., Hu, Z. B., & Li, L. M. (2021). [Polygenic risk score in personalized screening of lung cancer: a prospective cohort study in Chinese]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 42(3), 376-381. https://doi.org/10.3760/cma.j.cn112338-20210107-00013
Zhu, M, et al. "[Polygenic risk score in personalized screening of lung cancer: a prospective cohort study in Chinese]." Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi vol. 42,3 (2021): 376-381. doi: https://doi.org/10.3760/cma.j.cn112338-20210107-00013
Zhu M, Lyu J, Yu CQ, Huang YQ, Ma HX, Jin GF, Guo Y, Pei P, Chen ZM, Shen HB, Hu ZB, Li LM. [Polygenic risk score in personalized screening of lung cancer: a prospective cohort study in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Mar 10;42(3):376-381. doi: 10.3760/cma.j.cn112338-20210107-00013. Chinese. PMID: 34814406.
Copy Download .nbib Format: NLM
How lung cancer cells change identity.

eLife

von Itzstein MS, Drapkin BJ, Minna JD.
PMID: 34346867
Elife. 2021 Aug 04;10. doi: 10.7554/eLife.71610.

Changes in MAPK signaling allow lung cancer cells to transition between lineages that respond differently to treatment.

Cite
von Itzstein MS, Drapkin BJ, Minna JD. How lung cancer cells change identity. Elife. 2021;10doi: 10.7554/eLife.71610.
von Itzstein, M. S., Drapkin, B. J., & Minna, J. D. (2021). How lung cancer cells change identity. eLife, 10. https://doi.org/10.7554/eLife.71610
von Itzstein, Mitchell S, et al. "How lung cancer cells change identity." eLife vol. 10 (2021). doi: https://doi.org/10.7554/eLife.71610
von Itzstein MS, Drapkin BJ, Minna JD. How lung cancer cells change identity. Elife. 2021 Aug 04;10. doi: 10.7554/eLife.71610. PMID: 34346867; PMCID: PMC8337071.
Copy Download .nbib Format: NLM
Molecular events in lung carcinogenesis.

Hematology/oncology clinics of North America

Miller YE, Franklin WA.
PMID: 9137967
Hematol Oncol Clin North Am. 1997 Apr;11(2):215-34. doi: 10.1016/s0889-8588(05)70427-5.

Genetic alterations seen in established lung cancers are also often found in premalignant respiratory epithelium. The frequency, usual order, biologic consequences, and prognostic import of the alterations are only beginning to be studied. Increased knowledge regarding pulmonary premalignancy may...

Cite
Miller YE, Franklin WA. Molecular events in lung carcinogenesis. Hematol Oncol Clin North Am. 1997;11(2):215-34doi: 10.1016/s0889-8588(05)70427-5.
Miller, Y. E., & Franklin, W. A. (1997). Molecular events in lung carcinogenesis. Hematology/oncology clinics of North America, 11(2), 215-34. https://doi.org/10.1016/s0889-8588(05)70427-5
Miller, Y E, and Franklin, W A. "Molecular events in lung carcinogenesis." Hematology/oncology clinics of North America vol. 11,2 (1997): 215-34. doi: https://doi.org/10.1016/s0889-8588(05)70427-5
Miller YE, Franklin WA. Molecular events in lung carcinogenesis. Hematol Oncol Clin North Am. 1997 Apr;11(2):215-34. doi: 10.1016/s0889-8588(05)70427-5. PMID: 9137967.
Copy Download .nbib Format: NLM
Lung cancer biology: a genetic and genomic perspective.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Sánchez-Céspedes M.
PMID: 19451058
Clin Transl Oncol. 2009 May;11(5):263-9. doi: 10.1007/s12094-009-0353-7.

Lung cancer is the leading cause of death due to cancer in most western countries and, as tobacco consumption is not significantly decreasing worldwide, will remain so in the coming decades. Thus, in addition to preventing uptake and encouraging...

Cite
Sánchez-Céspedes M. Lung cancer biology: a genetic and genomic perspective. Clin Transl Oncol. 2009;11(5):263-9doi: 10.1007/s12094-009-0353-7.
Sánchez-Céspedes, M. (2009). Lung cancer biology: a genetic and genomic perspective. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 11(5), 263-9. https://doi.org/10.1007/s12094-009-0353-7
Sánchez-Céspedes, M. "Lung cancer biology: a genetic and genomic perspective." Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 11,5 (2009): 263-9. doi: https://doi.org/10.1007/s12094-009-0353-7
Sánchez-Céspedes M. Lung cancer biology: a genetic and genomic perspective. Clin Transl Oncol. 2009 May;11(5):263-9. doi: 10.1007/s12094-009-0353-7. PMID: 19451058.
Copy Download .nbib Format: NLM
Cell-free DNA Analysis in SCLC: Ready for Clinical Practice?.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Ahn MJ.
PMID: 29258667
J Thorac Oncol. 2018 Jan;13(1):10-11. doi: 10.1016/j.jtho.2017.10.003.

No abstract available.

Cite
Ahn MJ. Cell-free DNA Analysis in SCLC: Ready for Clinical Practice?. J Thorac Oncol. 2018;13(1):10-11doi: 10.1016/j.jtho.2017.10.003.
Ahn, M. J. (2018). Cell-free DNA Analysis in SCLC: Ready for Clinical Practice?. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 13(1), 10-11. https://doi.org/10.1016/j.jtho.2017.10.003
Ahn, Myung-Ju. "Cell-free DNA Analysis in SCLC: Ready for Clinical Practice?." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 13,1 (2018): 10-11. doi: https://doi.org/10.1016/j.jtho.2017.10.003
Ahn MJ. Cell-free DNA Analysis in SCLC: Ready for Clinical Practice?. J Thorac Oncol. 2018 Jan;13(1):10-11. doi: 10.1016/j.jtho.2017.10.003. PMID: 29258667.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 55 entries